| Pfizer AG - Ibrance 125 mg, Filmtabletten | | 69183 | | 03 | | Ibrance 125 mg | | Filmtabletten | | L01EF01 | | Palbociclib | | 06.09.2023 | | |
| | Composition | | palbociclibum 125 mg, cellulosum microcristallinum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, acidum succinicum, hypromellosum, E 171, triacetinum, E 132, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Palbociclibum | 125 mg |
| | BAG: Active Agent | Dose |
|---|
| Palbociclibum | 125 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Rubrum) | | | | Succinic Acid | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triacetinum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 21 | 1973.56 | 2162.80 | A | SL | No |
|
|
